A Commentary on “Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trial”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Commentary on “Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trial”

Published:2024-03-12 Issue: Volume: Page:
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Jia Wenqing¹²,Cheng Xi¹²,Zhao Ren¹²

Affiliation:

1. Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 200025

2. Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 200025

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trial;Huang;Int J Surg,2024

2. PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer;Cercek;N Engl J Med,2022

3. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Benson;J Natl Compr Canc Netw,2022

4. The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer;Glynne-Jones;Lancet Oncol,2021

5. RECIST 1.1-update and clarification: from the RECIST committee;Schwartz;Eur J Cancer,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP